Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial (vol 380, pg 1749, 2012)
Publication
, Journal Article
Lopes, RD; Al-Khatib, SM; Wallentin, L
Published in: LANCET
January 19, 2013
Duke Scholars
Published In
LANCET
ISSN
0140-6736
Publication Date
January 19, 2013
Volume
381
Issue
9862
Start / End Page
204 / 204
Publisher
ELSEVIER SCIENCE INC
Related Subject Headings
- General & Internal Medicine
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Lopes, R. D., Al-Khatib, S. M., & Wallentin, L. (2013). Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial (vol 380, pg 1749, 2012). LANCET, 381(9862), 204–204.
Lopes, R. D., S. M. Al-Khatib, and L. Wallentin. “Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial (vol 380, pg 1749, 2012).” LANCET 381, no. 9862 (January 19, 2013): 204–204.
Lopes RD, Al-Khatib SM, Wallentin L. Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial (vol 380, pg 1749, 2012). LANCET. 2013 Jan 19;381(9862):204–204.
Lopes, R. D., et al. “Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial (vol 380, pg 1749, 2012).” LANCET, vol. 381, no. 9862, ELSEVIER SCIENCE INC, Jan. 2013, pp. 204–204.
Lopes RD, Al-Khatib SM, Wallentin L. Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial (vol 380, pg 1749, 2012). LANCET. ELSEVIER SCIENCE INC; 2013 Jan 19;381(9862):204–204.
Published In
LANCET
ISSN
0140-6736
Publication Date
January 19, 2013
Volume
381
Issue
9862
Start / End Page
204 / 204
Publisher
ELSEVIER SCIENCE INC
Related Subject Headings
- General & Internal Medicine
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences